Last reviewed · How we verify
Initial insomnia
Approved treatments
- Ambien · Sanofi
Zolpidem binds to the benzodiazepine site of α1 subunit containing GABA A receptors, increasing chloride channel opening and inhibiting neuronal excitation. - Rozerem · Takeda
Rozerem works by activating the melatonin receptor type 1A to regulate sleep-wake cycles. - Sonata · Pfizer
- Rozerem · Northwestern University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Initial insomnia patent landscape — cliff calendar, originator estates, attackable patents
- Initial insomnia treatment landscape brief
- Initial insomnia treatment updates RSS
Frequently asked questions about Initial insomnia
What drugs treat Initial insomnia?
Tracked treatments include Ambien, Rozerem, Sonata.
What is the treatment for Initial insomnia?
Standard treatment for Initial insomnia includes Ambien, Rozerem, Sonata. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Initial insomnia patent cliff · Initial insomnia CI report
- Treatment: Ambien · Sanofi
- Treatment: Rozerem · Takeda
- Treatment: Sonata · Pfizer
- Treatment: Rozerem · Northwestern University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing